Identifying at-risk Medicare members and intervening upon them is a complex undertaking – below is your path to improving program efficiency and effectiveness.

When it comes to medication use, the ability to provide health plans with effective resources for monitoring and intervention is key to reducing costs and improving care quality ratings. RxAnte's latest enhancement provides a solution to address new prescription recommendation measures, on top of the existing triple-weighted adherence measures for 2020 CMS Star Ratings.

At RxAnte, we are often asked whether we use artificial intelligence (AI) as part of our adherence solution. The short answer to this question is ‘yes,’ but there is more nuance to this tool we find timely to explore. Here, we go beyond buzzwords like AI and into the significance of machine learning as part of a successful medication adherence solution.

RxAnte is proud to present “All Quality Improvement Patients” in our patented RxEffect tool. This update enables seamless care coordination by tracking patients over the current calendar year. RxEffect can now be the sole population management tool for medication-related quality improvement initiatives.

The FDA announced a recall of RASA prescriptions in mid-2018. The drug recall, followed by widespread negative press and medication switching, may have resulted in lower medication adherence among plan members that were prescribed these medications. RxAnte analyzed the impact of the 2018 RASA recalls on Prescription Drug Plan member populations.

The healthcare system once operated without really having to consider what patients or members wanted. We're here to help plans in the shift to patient-centered care.

In this blog series, we have been discussing how MAPD plans can improve their Star Ratings by using analytics to get greater control of their future in an uncertain market. Here we’ll be focusing on the role of analytics in predictive value and care delivery.

In our last blog post, we began to discuss how MAPD plans, amid so much market uncertainty, have the potential to not just control but improve their Star Ratings. Here, we build on that blog to discuss identifying the right members to reach and refining intervention methods to meet those members’ individual needs.

MAPD plan leaders face a series of growing challenges, ranging from rising cut points to evolving CMS rules to intensifying spending pressures. One of the biggest challenges, however, is within a plan’s control: CMS Star Ratings.